SI2054050T1 - Zdravljenje hrustanäśnih obolenj z fgf-18 - Google Patents

Zdravljenje hrustanäśnih obolenj z fgf-18

Info

Publication number
SI2054050T1
SI2054050T1 SI200731047T SI200731047T SI2054050T1 SI 2054050 T1 SI2054050 T1 SI 2054050T1 SI 200731047 T SI200731047 T SI 200731047T SI 200731047 T SI200731047 T SI 200731047T SI 2054050 T1 SI2054050 T1 SI 2054050T1
Authority
SI
Slovenia
Prior art keywords
fgf
treatment
cartilage disorders
cartilage
disorders
Prior art date
Application number
SI200731047T
Other languages
English (en)
Inventor
Alberto Gimona
Christoph H. Ladel
Baur Elmar Vom
Original Assignee
Ares Trading S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ares Trading S.A. filed Critical Ares Trading S.A.
Priority claimed from EP07802876A external-priority patent/EP2054050B1/en
Publication of SI2054050T1 publication Critical patent/SI2054050T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1825—Fibroblast growth factor [FGF]
SI200731047T 2006-08-25 2007-08-24 Zdravljenje hrustanäśnih obolenj z fgf-18 SI2054050T1 (sl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP06119557 2006-08-25
US84060006P 2006-08-28 2006-08-28
EP07802876A EP2054050B1 (en) 2006-08-25 2007-08-24 Treatment of cartilage disorders with fgf-18
PCT/EP2007/058830 WO2008023063A2 (en) 2006-08-25 2007-08-24 Treatment of cartilage disorders with fgf-18

Publications (1)

Publication Number Publication Date
SI2054050T1 true SI2054050T1 (sl) 2012-12-31

Family

ID=37684849

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200731047T SI2054050T1 (sl) 2006-08-25 2007-08-24 Zdravljenje hrustanäśnih obolenj z fgf-18

Country Status (11)

Country Link
CN (1) CN101505787B (sl)
BR (1) BRPI0715728A8 (sl)
DK (1) DK2054050T3 (sl)
ES (1) ES2392883T3 (sl)
MY (1) MY148277A (sl)
NZ (1) NZ574216A (sl)
PT (1) PT2054050E (sl)
RS (1) RS52710B (sl)
SI (1) SI2054050T1 (sl)
UA (1) UA99818C2 (sl)
ZA (1) ZA200900426B (sl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2013301606B2 (en) * 2012-08-06 2018-08-02 Merck Patent Gmbh Genetic markers for predicting responsiveness to FGF-18 compound
AU2015220781B2 (en) * 2014-02-20 2018-05-24 Merck Patent Gmbh FGF-18 in graft transplantation and tissue engineering procedures
WO2015124739A1 (en) * 2014-02-20 2015-08-27 Merck Patent Gmbh Implant comprising fgf-18
SG11201606505UA (en) * 2014-02-20 2016-09-29 Merck Patent Gmbh Fgf-18 compound dosing regimen
US20180000736A1 (en) * 2015-01-08 2018-01-04 University Of Iowa Research Foundation Methods for the regeneration of articular cartilage in vivo
WO2017008758A1 (en) * 2015-07-15 2017-01-19 Prosit Sole Biotechnology (Beijing) Co., Ltd Fusion polypeptides and methods of use
US20180236032A1 (en) * 2015-08-13 2018-08-23 Merck Patent Gmbh Combination composition comprising fgf-18 compound
US11904006B2 (en) 2019-12-11 2024-02-20 University Of Iowa Research Foundation Poly(diaminosulfide) particle-based vaccine
CN117721115A (zh) * 2022-09-06 2024-03-19 深圳瑞吉生物科技有限公司 用于治疗骨关节炎的mRNA及其制备方法与应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040136970A1 (en) * 2002-10-07 2004-07-15 Ellsworth Jeff L. Methods for administering FGF18
EP1896053B1 (en) * 2004-07-06 2018-10-31 ZymoGenetics, Inc. Pharmaceutical composition comprising fgf18 and il-1 antagonist and method of use
PT1828239E (pt) * 2004-12-10 2011-10-27 Zymogenetics Inc Produção de fgf18 em hospedeiros procarióticos

Also Published As

Publication number Publication date
BRPI0715728A8 (pt) 2018-04-03
MY148277A (en) 2013-03-29
UA99818C2 (ru) 2012-10-10
NZ574216A (en) 2011-11-25
CN101505787B (zh) 2013-09-04
PT2054050E (pt) 2012-09-17
RS52710B (en) 2013-08-30
ZA200900426B (en) 2010-04-28
CN101505787A (zh) 2009-08-12
DK2054050T3 (da) 2012-09-03
BRPI0715728A2 (pt) 2013-09-17
ES2392883T3 (es) 2012-12-14

Similar Documents

Publication Publication Date Title
PL2054050T3 (pl) Leczenie zaburzeń chrząstki z zastosowaniem FGF-18
EP1981526A4 (en) ADIPONECTIN FOR THE TREATMENT OF VARIOUS DISORDERS
ZA200900734B (en) Combination treatment for metabolic disorders
IL194189A0 (en) Combination treatment of metabolic disorders
IL230335A (en) A drug used to treat cartilage disease
ZA200900426B (en) Treatment of cartilage disorders with FGF-18
GB0703909D0 (en) Treatment of anxiety disorders
IL198488A0 (en) Treatment of pervasive developmental disorders
IL195906A0 (en) Alpha-aminoamide derivatives useful in the treatment of cognitive disorders
HK1247943A1 (zh) 發育相關疾病的治療
IL198196A0 (en) Treatment of demyelinating disorders with soluble lymphotoxin-beta-receptor
GB0619500D0 (en) Treatment of fibrosis
GB0607952D0 (en) Novel treatment
EP2037943A4 (en) TREATMENT OF BIND WEB DISEASES
PL1982178T3 (pl) Sposoby leczenia zaburzeń afektywnych
GB0604460D0 (en) Treatment
GB0623740D0 (en) Treatment of disease
HK1145282A1 (en) Treatment of sleep disorders
GB0602857D0 (en) The treatment of sialorrhoea
ZA200902765B (en) Treatment of pulp
GB0624439D0 (en) Technique for treatment of gall-and kidney-stones
GB0625602D0 (en) Treatment of sialorrhoea
GB0618705D0 (en) Treatment of joint disorders
GB0619218D0 (en) Treatment of conformational disorders
GB0602858D0 (en) The treatment of sialorrhoea